Safety and efficacy of ospemifene for the treatment of dyspareunia associated with vulvar and vaginal atrophy due to menopause

Safety and efficacy of ospemifene for the treatment of dyspareunia associated with vulvar and vaginal atrophy due to menopause

Gregory T Wurz, Chiao-Jung Kao, Michael W DeGregorio Department of Internal Medicine, Division of Hematology and Oncology, University of California Davis, Sacramento, CA, USA Abstract: During the menopausal transition, women experience a number of symptoms due to declining estrogen levels, includin...

Full description

Bibliographic Details
Main Authors: Wurz GT, Kao CJ, DeGregorio MW
Format: Article
Language:English
Published: Dove Medical Press 2014-11-01
Series:Clinical Interventions in Aging
Subjects:
Ospemifene SERM Dyspareunia Vaginal Dryness Vulvar and Vaginal Atrophy
Online Access:https://www.dovepress.com/safety-and-efficacy-of-ospemifene-for-the-treatment-of-dyspareunia-ass-peer-reviewed-article-CIA

Internet

https://www.dovepress.com/safety-and-efficacy-of-ospemifene-for-the-treatment-of-dyspareunia-ass-peer-reviewed-article-CIA

Similar Items